The fibrin
glue market is expected to grow at a CAGR of 10.9% between 2017-2023, to
reach $3.6 billion by 2023. Rising healthcare expenditure, increasing number of
surgical procedures and burn cases are some of the key factors, driving the
growth of the growth. Additionally, increasing prevalence of chronic diseases,
aging population, low chances of complications associated with these products
and increase in road accidents also support the growth of the global market.
In terms of application, the global fibrin glue market is
categorized into cardiac surgery, general surgery, vascular surgery, pulmonary
surgery, neurosurgery, lacerations of liver and spleen, burn bleeding,
orthopedic surgery, plastic surgery, wound management, and others. Some of the
other applications of fibrin glue based products include gastrointestinal
surgery, hernia management, forniceal reconstruction surgery, pterygium and
strabismus surgery, amniotic membrane transplantation, lamellar corneal
grafting, management of conjunctival wound leaks after trabeculectomy, lid
surgery, adnexal surgery. Cardiac surgery held the largest share of the global
fibrin glue market in 2016. Fibrin based sealants are used for hemostasis and
tissue adherence during cardiac surgeries to avoid the loss of blood, which is
one of the most critical issue encountered while performing a cardiac surgery.
Fibrin glue is made up of thrombin and fibrinogen which is applied on the tissue site for gluing them together. It is used in wound closure, bronchial fistulas, achieving hemostasis in liver and spleen trauma, and dura tears. Fibrin glue has sealing and hemostatic properties that help in gluing the tissues during a surgery. In clinical use, fibrin glue provides adequate tissue adhesion and shows quick hemostasis. The chances of complications during surgeries are quite less, with the use of fibrin glue. It reduces postoperative bleeding, postoperative scars, and infection when impregnated with antibiotics. As compared to sutures, fibrin glue causes less inflammation, faster surface rehabilitation, and less discomfort to the patient. Moreover, using fibrin glue in surgeries causes less post-operative pain, since the biomaterials of the fibrin glue are not toxic, inflammatory and allergenic. All the above factors associated with the use of fibrin glue, eventually lead to lower complications in various surgical procedures, thereby driving the growth of the fibrin glue market.
Explore Report at: https://www.psmarketresearch.com/market-analysis/fibrin-glue-market
Some of the key players operating in the global fibrin glue market include Vivostat A/S, Kaketsuken, Johnson & Johnson, Baxter International Inc., CSL Behring, Zimmer Biomet Holdings, Inc., Takeda Pharmaceutical Company Limited, Mallinckrodt Plc, Shanghai RAAS Blood Products Co. Ltd. and Hualan Biological Engineering Inc.
About P&S Market Research
P&S Market Research is a market
research company, which offers market research and consulting services for
various geographies around the globe. We provide market research reports,
industry forecasting reports, business intelligence, and research based
consulting services across different industry/business verticals.
As one of the top growing market
research agency, we’re keen upon providing market landscape and accurate
forecasting. Our analysts and consultants are proficient with business
intelligence and market analysis, through their interaction with leading
companies of the concerned domain. We help our clients with B2B market research
and assist them in identifying various windows of opportunity, and framing
informed and customized business expansion strategies in different regions.
Contact:
P&S Market Research
P&S Market Research
347, 5th Ave. #1402
New York City, NY - 10016
Toll-free: +1-888-778-7886 (USA/Canada)
Email: enquiry@psmarketresearch.com
Connect
with us: LinkedIn | Twitter | Google
+ | Facebook
Comments
Post a Comment